COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #210 of 237
12/14 Late treatment study
Tan et al., Virus Research, doi:10.1016/j.virusres.2020.198262 (Peer Reviewed)
A retrospective comparison of drugs against COVID-19
Source   PDF   Share   Tweet
Retrospective 333 patients in China, with only 8 HCQ patients, showing shorter duration of hospitalization with HCQ.

Tan et al., 12/14/2020, retrospective, China, Asia, peer-reviewed, 7 authors.
hospitalization time, 35.2% lower, relative time 0.65, p = 0.04, treatment 8, control 277.
Details of all 237 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit